Orchid may merge Orchid Research Laboratories with itself

31 Dec 2011 Evaluate

Orchid Chemicals & Pharmaceuticals (Orchid), a Chennai-based global pharma major, is considering a proposal whereby it may merge its wholly owned subsidiary - Orchid Research Laboratories with itself. The board will meet on January 07, 2012 to consider, discuss and transact this business.

Recently, Serum Institute of India (Serum) had hiked its stake in Orchid Chemicals & Pharmaceuticals. The institute had bought 5 lakh fresh shares for Rs 6.6 crore through open market transactions, according to the data available with the exchange.

Orchid is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was incorporated in the year 1992 as a 100% export-oriented unit.

Orchid Pharma Share Price

723.40 -16.85 (-2.28%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×